89bio 10K 2024 Annual report | ETNB Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: ACA, adulterated, Amarin, amenable, antidiscrimination, arbitrate, artificial, Assembly, authoritative, beneficiary, bidding, bifurcation, biosafety, biotech, Bipartisan, bore, bound, center, certainty, Cie, cirrhotic, clarify, clause, climate, comment, commerce, constantly, Dataset, de, debarment, Delinquent, detention, device, Disaggregation, docosahexaenoic, donut, efimosfermin, eicosapentaenoic, endorsed, erythema, estate, expedient, experimental, Explanation, FDCA, fifteen, focal, forfeited, FTC, gap, gene, GlaxoSmithKline, GLP, GMP, grandfathering, graph, hereof, HHS, hole, House, HQ, IBC, implanted, indirect, infused, ingredient, inhaled, instilled, instrument, intelligence, Interagency, interstate, irrespective, Kingdom, language, lawfully, learning, legitimate, lender, lot, machine, male, mandatorily, marking, MASLD, maximum, meant, misbranded, mislabeled, mode, Montgomery, move, narrowly, noncash, notified, notify, nucleic, official, overallotment, Parliament, Pennsylvania, pertinent, PHSA, Pilot, platform, pose, predetermined, premarket, proud, Radiological, rash, ratably, reacquisition, reassessed, redeemable, refinanced, refinancing, regime, regional, reinvestment, relaxation, rendered, Republic, restitution, revalue, Rezdiffra, run, satisfactory, scalability, scenario, seizure, sequestration, Shanghai, shelf, slower, somatic, steatotic, stratified, substantive, Suite, sunset, supplemented, thereto, threat, thyroid, UK, unblinded, unblinding, unfair, unlicensed, unobservable, untitled, Washington, whistleblower, withholding, WuXi, Zone

Removed: ACC, afflicted, ALT, Altimmune, ascending, attack, attestation, Belapectin, calculating, cGCP, commence, comparative, Convention, correlation, delivery, DHA, diabetic, DIN, Eli, emerging, Evinacumab, executed, filer, FXR, Galectin, Gilead, glycemic, golden, headache, hypersensitivity, incident, induced, Jumpstart, Lilly, Mexico, misappropriation, monkey, mouse, NAFLD, nominal, nonbinding, obese, occurring, oil, pandemic, panel, parachute, percentage, Pfizer, PK, pooled, PPAR, prevalent, Regeneron, relevance, renew, responded, Responder, revised, SAD, Sansome, scaled, Silicon, slightly, spiropiperidine, Stelic, subjected, supplier, SVB, taxation, taxed, Tirzepatide, Valley, Viking, wide, withdrew

89bio (ETNB) 10-K2024 FY Annual report

Content analysis